Thromboprophylaxis following cast immobilisation for lower limb injuries-survey of current practice in United Kingdom

Injury

Volumn 37, Issue 9, 2006, Pages 813-817

  Batra, Sameer ^a   Kurup, Harish ^a   Gul, Arif ^a   Andrew, J G ^a  

^a YSBYTY GWYNEDD   (United Kingdom)

Author keywords

Cast immobilisation; Lower limb injuries; Thromboprophylaxis

Indexed keywords

ACETYLSALICYLIC ACID; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

ARTICLE; CAST APPLICATION; CHEMOPROPHYLAXIS; COMPARATIVE STUDY; DEEP VEIN THROMBOSIS; HEALTH SURVEY; HIP ARTHROPLASTY; HOSPITAL; HUMAN; IMMOBILIZATION; KNEE ARTHROPLASTY; LEG INJURY; MEDICAL PERSONNEL; MEDICAL PRACTICE; PLASTER CAST; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK ASSESSMENT; STATISTICAL ANALYSIS; SURGEON; TELEPHONE; THROMBOSIS PREVENTION; UNITED KINGDOM;

ANTICOAGULANTS; CASTS, SURGICAL; FRACTURES, BONE; GREAT BRITAIN; HUMANS; LEG INJURIES; PROFESSIONAL PRACTICE; RISK FACTORS; THROMBOEMBOLISM;

EID: 33747133280     PISSN: 00201383     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.injury.2006.03.016     Document Type: Article

References (39)

1. Abelseth G., Buckley R.E., Pineo G.E., et al. Incidence of deep-vein thrombosis in patients with fractures of the lower extremity distal to the hip. J Orthop Trauma 10 (1996) 230-235
2. Anderson F.A., Wheeler H.B., Goldberg R.J., et al. Physician practices in the prevention of venous thromboembolism. Ann Intern Med 115 (1991) 591-595
3. Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy. I. Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 308 (1994) 81-106
4. Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy. II. Maintenance of vascular graft or arterial patency by antiplatelet therapy. BMJ 308 (1994) 159-168
5. Bauer G. Thrombosis following leg injuries. Acta Chir Scand 90 (1944) 229-249
6. Bergqvist D., Matzsch T., Jendteg S., et al. The cost-effectiveness of prevention of post-operative thromboembolism. Acta Chir Scand Suppl 556 (1990) 36-41
7. British Committee for Standards in Haematology. http://www.bcshguidelines.com/pdf/Heparin_070705.pdf.
8. Cohen A., and Quinlan D. PEP trial. Pulmonary embolism prevention. Lancet 356 9225 (2000) 247
9. Collins R., Scrimgeour A., Yusuf S., and Peto R. Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin: overview of results of randomised trials in general, orthopaedic, and urologic surgery. N Engl J Med 318 (1988) 1162-1173
10. Consensus Conference. Prevention of venous thrombosis and pulmonary embolism. JAMA 256 (1986) 744-749
11. Consensus Statement (Guidelines according to scientific evidence). Prevention of venous thromboembolism. Angiology 16 (1997) 3-38
12. Encke A. Thromboembolieprophylaxe in der Allgemeinchirurgie. Chiurg 63 (1992) 264-270
13. Geerts W.H., Code K.I., Jay R.M., et al. A prospective study of venous thromboembolism after major trauma. N Engl J Med 331 24 (1994) 1601-1606
14. Geerts W.H., Heit J.A., and Clagett G.P. Prevention of venous thromboembolism. Chest 119 (2001) 132S-175S
15. Hirsh J, Dalen J, Guyatt G. The sixth (2000) ACCP guidelines for antithrombotic therapy for prevention and treatment of thrombosis: American College of Chest Physicians. Chest 2001;119:Suppl US-2S.
16. Hjelmstedt A., and Bergvall U. Incidence of thrombosis in patients with tibial fractures. Acta Chir Scand 134 (1968) 209-218
17. International Consensus Statement. Prevention of venous thromboembolism. London: Med-Orion Publishing; 1997.
18. Jorgensen PS, Warming T, Hansen K. Low molecular weight heparin (Innohep) as thromboprophylaxis in outpatients with a plaster cast: a venografic controlled study. Thromb Res 2002;15;105(6): 477-80.
19. Kakkar V.V. Prevention and management of venous thrombosis. Br Med Bull 50 4 (1994) 871-903
20. Kakkar W. Prevention of venous thromboembolism. In: Bloom A.L., Forbes C.D., Thomas D.P., and Tuddenham E.G.D. (Eds). Haemostasis and thrombosis. 3rd ed. (1994), Churchill Livingstone, Edinburgh 1361-1379
21. Kock H.-J., Schmit-Neuerburg K.P., Hanke J., et al. Thromboprophylaxis with low-molecular-weight heparin in outpatients with plaster-cast immobilisation of the leg. Lancet 346 (1995) 459-461
22. Kujath P., Spannagel U., and Habscheid W. Incidence and prophylaxis of deep venous thrombosis in outpatients with injury of the lower limb. Haemostasis 23 Suppl 1 (1993) 20-26
23. Lassen M.R., Borris L.C., and Nakov R.L. Use of the low-molecular-weight heparin reviparin to prevent deep-vein thrombosis after leg injury requiring immobilization. N Engl J Med 347 10 (2002) 726-730
24. Leizorovicz A., Haugh M.C., Chapuis F.R., et al. Low molecular weight heparin in prevention of perioperative thrombosis. BMJ 305 (1992) 913-920
25. Mahe I., Bergmann J.F., Mahe E., and Caulin C. PEP trial. Pulmonary Embolism Prevention. Lancet 356 9225 (2000) 248
26. Moser K.M., and LeMoine J.R. Is embolic risk conditioned by location of deep vein thrombosis. Am Intern Med 94 (1981) 439-444
27. Nesheiwat F., and Sergi A.R. Deep venous thrombosis and pulmonary embolism following cast immobilization of the lower extremity. J Foot Ankle Surg 35 6 (1996) 590-594
28. Nicolaides A., Kakkar W., Field E., and Renney J.T. The origin of deep vein thrombosis: a venographic study. Br J Radiol 44 (1971) 653
29. Nylander G., and Semb H. Veins of the lower part of the leg after tibial fractures. Surg Gynecol Obstet 134 (1972) 974-976
30. Oster G., Tuden R.L., and Colditz G.A. A cost-effective analysis of prophylaxis against deep-vein thrombosis in major orthopedic surgery. JAMA 257 (1987) 203-208
31. Pulmonary Embolism Trial Collaborative Group. Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: pulmonary embolism prevention (PEP) trial. Lancet 355 9212 (2000) 1295-1302
32. Reilmann H., Weinberg A.M., Forster E.E., and Happe B. Prevention of thrombosis in ambulatory patients [in German]. Orthopade 22 (1993) 117-120
33. Rodgers A., Gray H., and MacMahon S. Pharmacological thromboprophylaxis in hip and knee surgery: a survey of New Zealand orthopaedic surgeons. Aust NZ J Surg 64 (1994) 167-172
34. Samama M.M. An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients: the Sirius study. Arch Intern Med 160 22 (2000) 3415-3420
35. Scottish Intercollegiate Guidelines Network (SIGN). http://www.sign.ac.uk/guidelines/fulltext/62/index.html.
36. Spannagel U., and Kujath P. Low molecular weight heparin for the prevention of thromboembolism in outpatients immobilized by plaster case. Semin Thromb Hemost 19 Suppl 1 (1993) 131-141
37. Spieler U., Peter B., and Brunner U. Traumatische Thrombosen im tiefen Venensystem bei frischen Unterschenkelfrakturen. Sehweiz med Wschr 102 (1972) 1535-1540
38. THRiFT II. Risk of and prophylaxis for venous thromboembolism in hospital patients. Phlebology 13 (1998) 87-97
39. Thromboembolic Risk Factors (THRIFT) Consensus Group. Risk of and prophylaxis for venous thromboembolism in hospital patients. BMJ 305 (1992) 567-574